Comparison of PCR methods for detecting fetal RhD in maternal plasma

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 1, 2009, Pages 24-28

  Atamaniuk, Johanna ^a   Stuhlmeier, Karl M ^b   Karimi, Alireza ^a   Mueller, Mathias M ^a  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Cell free DNA; Fetal RhD; PCR; Plasma DNA

Indexed keywords

DNA; RHESUS D ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CELL FREE SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC ACCURACY; DNA PROBE; EXON; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; MALE; MATERNAL PLASMA; MELTING POINT; REAL TIME POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; SEX DETERMINATION; THIRD TRIMESTER PREGNANCY;

ADULT; DIAGNOSTIC ERRORS; DNA; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION (ANALYSIS); STATISTICS, NONPARAMETRIC;

EID: 58849097751     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20282     Document Type: Article

References (13)

1. Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion 1999;39:169-173.
2. Pertl B, Pieber D, Panzitt T, et al. RhD genotyping by quantitative fluorescent polymerase chain reaction: a new approach. BJOG 2000;107:1498-1502.
3. Cotorruelo C, Biondi C, Garcia Borras S, Di Monaco R, Racca A. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn. Clin Exp Med 2002;2:77-81.
4. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.
5. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004;1022:119-123.
6. Bianchi DW, Lo YM. Fetomaternal cellular and plasma DNA trafficking: The Yin and the Yang. Ann N Y Acad Sci 2001;945: 119-131.
7. Bischoff FZ, Nguyen DD, Marquez-Do D, Moise Jr KJ, Simpson JL, Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 1999;6:64-69.
8. Siva SC, Johnson SI, McCracken SA, Morris JM. Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation. Aust N Z J Obstet Gynaecol 2003;43:10-15.
9. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta-analysis. Am J Obstet Gynecol 2006;195:1163-1173.
10. Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006;46:2142-2148.
11. Clausen FB, Krog GR, Rieneck K, et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 2005;25:1040-1044.
12. Krog GR, Clausen FB, Dziegiel MH. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods. Transfusion 2007;47:715-722.
13. Hromadnikova I, Vechetova L, Vesela K, et al. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 2005;20: 275-280.